デフォルト表紙
市場調査レポート
商品コード
1609662

日本のPOC診断市場レポート:製品タイプ、プラットフォーム、処方モード、エンドユーザー、地域別、2025年~2033年

Japan Point of Care Diagnostics Market Report by Product Type, Platform, Prescription Mode, End User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 121 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.95円
日本のPOC診断市場レポート:製品タイプ、プラットフォーム、処方モード、エンドユーザー、地域別、2025年~2033年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のPOC診断市場の市場規模は2024年に17億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに38億米ドルに達し、2025~2033年の成長率(CAGR)は9.2%に達すると予測しています。がん、糖尿病、心血管疾患のような慢性疾患の有病率の増加、地域診療所、薬局、在宅環境への嗜好の変化、高齢化人口の拡大が市場を牽引する主要因のいくつかです。

本レポートで扱う主な質問

  • 日本のPOC診断市場はこれまでどのように推移し、今後どのように推移するのか?
  • COVID-19が日本のPOC診断市場に与えた影響は?
  • 日本のPOC診断市場の製品タイプ別の内訳は?
  • 日本のPOC診断市場のプラットフォーム別の内訳は?
  • 日本のPOC診断市場の処方形態別の内訳は?
  • 日本のPOC診断市場のエンドユーザー別の内訳は?
  • 日本のPOC診断市場のバリューチェーンにはどのような段階がありますか?
  • 日本のPOC診断における主な促進要因と課題は何か?
  • 日本のPOC診断市場の構造と主要プレーヤーは?
  • 日本のPOC診断市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のPOC診断市場-イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のPOC診断市場情勢

  • 過去および現在の市場動向(2019年~2024年)
  • 市場予測(2025-2033)

第6章 日本のPOC診断市場:製品タイプ別の内訳

  • 血糖値モニタリングキット
  • 心臓代謝モニタリングキット
  • 妊娠・不妊検査キット
  • 感染症検査キット
  • コレステロール検査ストリップ
  • 血液検査キット
  • その他

第7章 日本のPOC診断市場:プラットフォーム別の内訳

  • ラテラルフローアッセイ
  • ディップスティック
  • マイクロ流体
  • 分子診断
  • 免疫測定

第8章 日本のPOC診断市場:処方モード別の内訳

  • 処方箋ベース検査
  • OTC検査

第9章 日本のPOC診断市場:エンドユーザー別の内訳

  • 専門診断センター
  • 在宅ケア
  • 研究ラボ
  • その他

第10章 日本のPOC診断市場:競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本のPOC診断市場:業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112024A19664

Japan point of care diagnostics market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 9.2% during 2025-2033. The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, shifting preferences towards community clinics, pharmacies, and home settings, and the expanding aging population represent some of the key factors driving the market.

Point of care diagnostics (POCD) refers to medical tests conducted at or near the site of patient care, providing rapid results for immediate clinical decisions. It is user-friendly, requiring minimal training for healthcare professionals and encompasses a broad spectrum of tests for infectious diseases, chronic conditions, pregnancy, and various biomarkers. It enhances accessibility to medical testing, especially in resource-limited settings. It aids in preventing the spread of contagious diseases within communities or healthcare facilities. It reduces the need for multiple clinical visits, offering convenience and potentially lowering healthcare costs. It assists in managing and adjusting treatment plans based on real-time data. It is widely used in emergency medicine to quickly assess and diagnose critical conditions, such as cardiac events, sepsis, or respiratory distress.

Japan Point of Care Diagnostics Market Trends:

The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, coupled with this rising need for regular monitoring and immediate medical attention, represents one of the primary factors driving the demand for POCD in Japan. Additionally, the expanding aging population and the increasing hospitalization rates are facilitating the market growth. Along with this, rapid urbanization, changing lifestyles of individuals, and the rising risk of lifestyle-related diseases, such as obesity and hypertension, are driving the market in the country. POCD facilitates the timely monitoring and management of these conditions, leading to greater demand for POC testing devices. Apart from this, shifting preferences towards community clinics, pharmacies, and home settings are influencing the market positively. Moreover, governing authorities of the country are continuously focusing on the modernization of the healthcare sector, which is offering a favorable market outlook. They are implementing several initiatives and offering favorable reimbursement rates that encourage technological integration in healthcare services. Furthermore, the robust technology sector of Japan is actively engaged in miniaturization and automation, ensuring that POCDs meet the highest standards of reliability and usability. Along with this, rising collaborations between healthcare providers, diagnostic companies, and research institutions in Japan are creating a positive outlook for the market. These partnerships foster innovation and enable the development of tailored POC solutions for specific medical conditions. In addition, the rising shift towards preventive healthcare and early disease detection is bolstering the market growth. POC diagnostics empower individuals to monitor their health regularly, fostering a proactive approach to healthcare and reducing the burden on healthcare facilities. The growing awareness among the Japanese population about the importance of regular health check-ups is influencing the market positively.

Japan Point of Care Diagnostics Market Segmentation:

Product Type Insights:

  • Blood-Glucose Monitoring Kit
  • Cardio-Metabolic Monitoring Kit
  • Pregnancy and Fertility Testing Kit
  • Infectious Disease Testing Kit
  • Cholesterol Test Strip
  • Hematology Testing Kit
  • Others

Platform Insights:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Prescription Mode Insights:

  • Prescription-Based Testing
  • OTC Testing

End User Insights:

  • Professional Diagnostic Centers
  • Home Care
  • Research Laboratories
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan point of care diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan point of care diagnostics market?
  • What is the breakup of the Japan point of care diagnostics market on the basis of product type?
  • What is the breakup of the Japan point of care diagnostics market on the basis of platform?
  • What is the breakup of the Japan point of care diagnostics market on the basis of prescription mode?
  • What is the breakup of the Japan point of care diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan point of care diagnostics market?
  • What are the key driving factors and challenges in the Japan point of care diagnostics?
  • What is the structure of the Japan point of care diagnostics market and who are the key players?
  • What is the degree of competition in the Japan point of care diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Point of Care Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Point of Care Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Point of Care Diagnostics Market - Breakup by Product Type

  • 6.1 Blood-Glucose Monitoring Kit
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Cardio-Metabolic Monitoring Kit
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Pregnancy and Fertility Testing Kit
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Infectious Disease Testing Kit
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Cholesterol Test Strip
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 Hematology Testing Kit
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 Others
    • 6.7.1 Historical and Current Market Trends (2019-2024)
    • 6.7.2 Market Forecast (2025-2033)

7 Japan Point of Care Diagnostics Market - Breakup by Platform

  • 7.1 Lateral Flow Assays
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Dipsticks
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Microfluidics
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Molecular Diagnostics
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Immunoassays
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)

8 Japan Point of Care Diagnostics Market - Breakup by Prescription Mode

  • 8.1 Prescription-Based Testing
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 OTC Testing
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Point of Care Diagnostics Market - Breakup by End User

  • 9.1 Professional Diagnostic Centers
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Home Care
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Research Laboratories
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2019-2024)
    • 9.4.2 Market Forecast (2025-2033)

10 Japan Point of Care Diagnostics Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Point of Care Diagnostics Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix